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A B S T R A C T
Background: A recent Cochrane review of randomised trials identiﬁed a lack of evidence for interventions
provided to drug-using offenders. We use routine data to address whether contact with treatment
services reduces heroin users’ likelihood of a future acquisitive offence or drug-related poisoning (DRP)
death.
Methods: Heroin-users were identiﬁed from probation assessments and linked to drug-treatment,
mortality and offending records. The study cohort was selected to ensure that the subject was not: in
prison, in treatment or had recently left treatment. Subjects were classed as initiators if they attended a
triage appointment within two weeks of their assessment; non-initiators otherwise. Initiator and non-
initiators were compared over a maximum of one year, with respect to their risk of recorded acquisitive
offence or DRP-death. Balance was sought using propensity score matching and missing data were
accounted for using multiple imputation.
Results: Nine percent of assessments identiﬁed for analysis were classed as initiators. Accounting for
observed confounding and missing data, there was a reduction in DRPs associated with initiator
assessments, however there was uncertainty around this estimate such that a null-effect could not be
ruled out (HR: 0.42, 95% CI 0.17–1.04). There was no evidence of a decrease in the recidivism risk, in fact
the analysis showed a small increase (HR: 1.10, 95% CI 1.02–1.18).
Conclusion: For heroin-using offenders, initial contact with treatment services does not appear to reduce
the likelihood of a future acquisitive offence.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
Endemic heroin use is associated with signiﬁcant public health
and social problems (UN Ofﬁce On Drugs and Crime, 2010): in
particular, high rates of mortality (Degenhardt et al., 2013; Pierce,
Bird, Hickman, & Millar, 2015) and acquisitive offending (Bennett,
Holloway, & Farrington, 2008; Pierce, Hayhurst et al., 2015). In the
UK, structured addiction treatment is commissioned with the aim
of reducing users’ dependence on illicit drugs and minimizing the
harms associated with these drugs, including premature death and
offending (Home Ofﬁce, 2010). The front-line intervention offered
for heroin dependence is opioid substitution therapy (OST) with
methadone or buprenorphine (National Treatment Agency for
Substance Misuse, 2006). Psychological support is also available
but recommended only as an adjunct to OST (National Treatment
Agency for Substance Misuse, 2006). In the UK, the treatment
pathway for patients with heroin dependence is determined
during a triage appointment with a drugs key-worker (National
Treatment Agency for Substance Misuse, 2006).
In medical and social research, randomised controlled trials
(RCT’s) are considered optimal for assessing the effectiveness of an
intervention (Campbell, Stanley, & Gage, 1966). However, RCTs and
meta-analysis of interventions provided for heroin users have been
underpowered to detect changes in mortality or offending and
usually focus on intermediate outcomes such as reduced illicit
opioid use and treatment retention (Amato et al., 2013; Amato,
Minozzi, Davoli, & Vecchi, 2011a; Amato, Minozzi, Davoli, & Vecchi,
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2011b; Mattick, Breen, Kimber, & Davoli, 2009; Mattick, Breen,
Kimber, & Davoli, 2014). For example, a recent meta-analysis of
RCTs for OST offered for heroin-using offenders was unable to
detect an effect on future arrests (1 study, 62 subjects, RR: 0.60,
95% CI: 0.32–1.14) or incarceration (3 studies, 472 subjects, RR:
0.77, 95% CI: 0.36–1.64) (Perry et al., 2015).
Cohorts identiﬁed from routinely collected data can provide the
necessary power to investigate rarer outcomes (Bird, 2008). Many
studies of addiction treatment aim to quantify the effect of being
treated by contrasting periods in and out of treatment. However,
this will be a biased comparison if there are non-random reasons
for why patients leave treatment which are related to the outcome
under consideration. To account for this confounding bias,
confounding variables should be measured over follow-up;
however, such information is rarely available or incomplete. This
problem can be avoided by analysing subjects according to initial
treatment status — something closer to the intention to treat
principle routinely used in randomised controlled trials. Treatment
and control subjects can then be balanced prior to follow-up, using
propensity score methods.
This study used a large, observational, record-linkage dataset
from England, to analyse the effect of initiating drug-treatment on
subsequent offending and mortality. We focus on the effect of
initiating treatment, ignoring the fact that many who begin
treatment may drop-out early. Therefore, our study aims to
quantify the impact of a policy where everybody with heroin
dependence attends a triage appointment. The study is designed to
best emulate what would have occurred during an RCT — an
approach that has been recommended in pioneering work from
other areas of clinical research (Danaei, Rodriguez, Cantero, Logan,
& Hernan, 2013; Hernan et al., 2008; Toh & Manson, 2013).
We use this design to investigate two hypotheses: for heroin
users identiﬁed in the criminal justice system, does initiating
contact with treatment services reduce the risk of: (a) a future
drug-related poisoning death and (b) a recorded acquisitive
offence.
Methods
A cohort of heroin users was identiﬁed from probation
(offender management) assessments, using inclusion and exclu-
sion criteria. Following an eligible probation assessment, if
subjects were recorded in treatment data as attending a triage
appointment within two weeks they were classed as an initiator;
otherwise they were classed as a non-initiator. Outcome events
were deﬁned as a drug-related poisoning (DRP) death or a day
when the subject committed a recorded acquisitive offence over a
maximum of one-year. Time-to-outcome was compared between
initiators and non-initiators, irrespective of future treatment
status. Balance between initiators and non-initiators was sought
by matching on propensity scores calculated using an extensive set
of baseline covariates available from probation assessment and
historical offending records.
Datasets
Data were extracted from the Drug Data Warehouse — a
collection of case-linked national datasets on substance users in
England, covering the period 1st April 2005 to 31st March 2009
(Millar et al., 2012).
The analysis cohort was identiﬁed from probation assessments
recorded on the Offender Assessment System (OASys) database.
OASys contains information from a structured interview between
offender and probation ofﬁcer with the aim of assessing an
offender’s recidivism risk and to identify particular needs (National
Probation Services, 2003). This assessment can form part of a pre-
sentence report, to aid the judge’s sentencing decision, or can be
used to help probation services manage offenders post-sentence,
for example after release from prison on licence (i.e. serving the
remainder of a sentence in the community, under regular
supervision by probation services).
Treatment data were obtained from the National Drug
Treatment Monitoring System (NDTMS). NDTMS collects data on
contact between substance-use disorder patients and structured
treatment delivered by National Health Service and third-sector
providers, which together account for almost all such provision in
England. When a substance-use disorder patient initially contacts
treatment services they undergo a triage appointment with a key-
worker. The aim of this appointment is to assess the patient’s needs
and determine the most appropriate treatment. After this
appointment, clients may be offered treatment within the
assessing treatment agency, or onward referral to another service.
Details of sanctioned offending were determined through
Police National Computer (PNC) records, for all offences that
occurred since the age of ten, and resulted in a conviction, caution,
warning or reprimand. A death occurring over follow-up was
established from national mortality records.
Linkage was done based on a minimal identiﬁer (initials, date of
birth and gender). Additionally, criminal-justice system databases
included an individually unique CJS identiﬁer. Due to data release
requirements, instances where more than one CJS identiﬁer linked
to a single minimal identiﬁer were removed because this provided
evidence that multiple subjects shared the latter details. This
affected 33.6% of assessments in OASys and these were dropped
from the analysis. Identiﬁers were fully anonymised prior to their
release to the study team.
Inclusion/exclusion criteria
Probation records were included in the analysis cohort provided
the interviewed subject: was assessed between April 1 2005 and
March 1 2009; reported weekly or more frequent use of heroin (by
any route of administration); was aged 18–64 years. After resulted
in 117,044 assessments (see Fig. 1).
A priori criteria were established so that, in turn, probation
records were excluded from the study if:
(i) The assessment was for a pre-sentence report which was
associated with a subsequent prison sentence (n = 22,097)
Fig. 1. Flow-chart of selection of probation assessments into the analysis cohort.
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(ii) The assessment was post-sentence but carried out in prison
(n = 15,169)
(iii) The subject was already in treatment at the time of their
probation assessment (n = 51,930)
(iv) The subject had left treatment in the four weeks prior to their
probation assessment (n = 3188)
(v) The subject was already in the study at the time of assessment
via a previous assessment (n = 9844)
The rationale for these exclusion criteria were: (i and ii) time
incarcerated will be associated with lower DRPs, due to restricted
access to drugs, and (naturally) offending risk and our data did not
include date of prison release; (iii) the focus of the analysis is on the
effect of initiating treatment, not on the effect of having been in
treatment for some time; (iv) the four weeks following treatment
cessation are known to confer elevated overdose risk (Pierce, Bird,
et al., 2016) and so this cut-off was chosen as a wash-out period,
prior to subsequent treatment; (v) was to ensure that no person
could be entered into the analysis if they were already under
observation.
Exposure deﬁnition
We designated a two-week classiﬁcation phase that followed an
eligible probation assessment. During this period, if the subject
attended a triage appointment for opioid misuse treatment, as
recorded in NDTMS data, they were classiﬁed as an initiator and the
remainder who did not have any treatment contact were deﬁned as
a non-initiator. This two week cut-off was chosen by members of
the research team, prior to analysis, as it was considered that a
shorter period missed too many initiators, and a longer period
would mean that the variables collected at the assessment would
no longer be relevant.
Fourteen deaths occurred during the classiﬁcation phase and
these were excluded from analysis. Follow-up began after this
period and ended on the earliest date of: the outcome under
consideration, the end of data collection (31st March 2009), death
from any cause, or one year after baseline assessment. The
resulting analysis dataset consisted of 14,802 assessments
(13,204 individuals).
Outcome deﬁnitions
An acquisitive-offence event was deﬁned using the offence
date, recorded in the PNC, for sanctioned offences with an offence
code identifying the crime categories: theft, fraud and forgery,
burglary, robbery, drug supply (including intent to supply) and
prostitution. The PNC does not differentiate between drug-supply
for material gain and ‘social supply’, whereby drugs are shared
between individuals. Inclusion of drug-supply in the deﬁnition of
‘acquisitive offences’ is intended to increase its sensitivity, at the
cost of some speciﬁcity. A fatal drug-related poisoning (DRP) was
deﬁned according to the UK harmonised deﬁnition (Ofﬁce for
National Statistics, 2016) using the ICD-10 code (World Health
Organization, 2010) for the underlying cause of death.
Propensity scores
Propensity scores give the probability of a subject being an
initiator, conditional on a set of baseline covariates. If the model
used to predict propensity scores is correctly speciﬁed, then the
covariates will be evenly distributed between subjects with the
same propensity score. It follows that if all possible confounders
are used to predict the propensity score – that is all factors are
identiﬁed which can inﬂuence both self-classiﬁcation and outcome
– then the contrast between initiator and non-initiators with the
same propensity score will be unconfounded (Rosenbaum & Rubin,
1985).
Propensity scores were calculated using a logistic regression
model which included variables available in the OASys system or
calculated from historical PNC records. For ease of presentation,
these covariates were grouped into eight types: demographic;
relating to the assessment; relating to the current offence; drug
use; alcohol use; employment and housing; mental and physical
wellbeing; and offending history. All identiﬁed covariates were
used to calculate the propensity scores. A description of each
covariate is available in Appendix A in Supplementary material.
Propensity score matching and assessing balance
Once propensity scores were calculated, the variable matching
approach recommended in Rassen et al. (2012) was adopted, with up
to ﬁve non-initiators selected for each initiator. The matching
algorithm is described in detail in Appendix B in Supplementary
material. The calliper distance was set as 20% of the standard
deviation of the logit of the propensity scores (Austin, 2011a).
Balance for each covariate, both prior to and post matching, was
assessed using its standardised distance between initiator and non-
initiators. This was calculated for each initiator assessment’s worst
match (i.e. the match with the greatest propensity score distance)
to get a conservative measure of balance. The resulting model was
considered poorly balanced if the standardised difference between
pairs was >10% of the standard deviation (Austin, 2011b).
Analysis model
Proportional hazard models were ﬁtted, contrasting the time to
event (acquisitive crime or DRP) between initiators and non-
initiators. Subjects entered the risk set after the classiﬁcation phase
(i.e. two week’s post-assessment). Multiple assessments belonging
to the same individual were accounted for by adjusting the
standard errors using the Huber-White sandwich estimator.
The same propensity score matched groups were used for the
analyses of both outcomes. The matched sample was analysed by
stratifying the Cox model on each matched group. Non-initiators
were given weights equal to the inverse of the number of non-
initiators in that matched group. For example, within a group with a
matching ratio of 1:4 each non-initiator would be given 1/4 weights
and the initiator was given a weight of one. The Schoenfeld residuals
were examined for departures from proportional hazards.
Missing data
Thirty percent (4480/14,802) of assessments in the analysis
dataset had missing data for at least one of the baseline covariates
used to calculate the propensity score. Initially those with missing
data were excluded from the matched analysis. To account for
potential selection bias in this approach, those with missing
information were incorporated into the analysis using multiple
imputation (ICE command, Stata 13) (Royston & White, 2011).
Missing data distributions were calculated using all variables in
Appendix A in Supplementary material, plus indicators for being
an initiator and whether the subject had a death or an offence over
follow-up. Ten imputed datasets were constructed and a propen-
sity score model was ﬁtted to each. The multiple imputation
propensity score was taken as the mean of these and the matching
process was repeated (Hill, 2004).
Sensitivity analysis
A planned sensitivity analysis was conducted to test the
robustness of the results to one element of the study design: the
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deﬁnition of an initiator. This was performed by changing the
length of the classiﬁcation phase from two weeks to one week and
then four weeks.
Results
There were 14,802 assessments identiﬁed for analysis and
12,948 person years of follow-up (Table 1). Nine percent of
assessments (1271) were classed as initiators.
Prior to matching, the standardised difference between initiators
and non-initiators was small for many covariates (Table 2). For
example, initiators had a similar proportion of women and a similar
mean age to non-initiators. There were differences with respect to
the purpose of the baseline assessment: initiators were more likely
to have been assessed as the result of a pre-sentence report, rather
than a sentence review or start of their release on licence. Initiators
were also more likely to be daily users of heroin and less likely to
have declared alcohol use as a signiﬁcant problem.
Overall there was good overlap of propensity scores between
initiators and non-initiators, implying that there was good
availability of potential matches (Fig. 2). Following multiple
imputation, to account for missing data, 95% of initiators (1201)
and 37% of non-initiators (5047) were included in the analysis
dataset.
After matching, all standardised differences were within the
pre-speciﬁed 10% threshold, indicating that the propensity score
matching approach was successful in achieving covariate balance
between initiators and non-initiators (Table 2). Therefore, further
models which included interactions and higher order terms were
judged unnecessary.
Drug-related poisoning risk initiators vs. non-initiators
There were 84 DRPs over follow-up, resulting in a mortality rate
of 6.5 DRPs per 1000 person years (95% CI: 5.2–8.0). The rate of
DRPs for initiators was less than half that for non-initiators
(Table 3). In the unmatched proportional hazard analysis, there
was insufﬁcient evidence to conclude a reduction in DRP following
initiator-assessments (p = 0.12). In the matched analyses there was
modest evidence of a reduction in DRP deaths (p = 0.06).
Acquisitive offending risk initiators vs. non-initiators
The overall rate of recorded acquisitive offences was 0.91 per
person year (95% CI: 0.86–0.96). The risk of an acquisitive offence
was 22% higher following initiator assessments than following non-
initiator assessments (Table 4). In the matched analysis, the
difference narrowed to 8%, and then 10% after multiple imputation.
Sensitivity analyses
Changing the length of the classiﬁcation phase from two weeks
to one week or four weeks did not substantially change the
estimates with respect to DRPs or acquisitive offences, although
the p-values for the DRP analysis got larger (Appendix C in
Supplementary material).
Discussion
There was a modestly signiﬁcant reduction in DRP deaths
associated with being an initiator that is consistent with the
hypothesis that initial treatment contact is effective in reducing
DRP deaths. However, the current study, in isolation, cannot
establish this due to a lack of statistical power, as indicated by the
wide conﬁdence intervals. In contrast, the study found that, after
adjusting for observed confounding, initiators had a ten percent
higher offending rate, with lower 95% conﬁdence interval close to
neutrality. This result is at odds with the hypothesis that treatment
contact is effective at reducing offending for offending-heroin
users.
The study was designed to emulate elements of a controlled
trial: using eligibility criteria; balancing groups at baseline; and
analysing groups as treatment was initially planned, regardless of
future treatment status. A large proportion of assessments were
excluded from the analysis, mostly because, at the time of their
assessment, the subject was already in treatment or they were
incarcerated. These exclusion criteria were purposefully estab-
lished, prior to analysis, to focus the study on the question: for
heroin users identiﬁed from community probation, what is the
effect of initiating contact with drug treatment services on future
DRP mortality/acquisitive offending? Adopting eligibility criteria
matches what occurs in randomised trials and has been
recommended for wider use in observational research (Danaei
et al., 2013; Hernan et al., 2008).
Diagnostics showed that propensity score matching provided a
cohort where the initiator and non-initiator assessments were
balanced on observed covariates. However, we cannot rule out
residual confounding because either: (i) there are further
unobserved variables which explain group differences and are
also related to outcome; or (ii) the covariates were poorly
measured so that they failed sufﬁciently to capture the true
difference.
Table 1
Summary of key statistics, initiators and non-initiators.
Statistic Initiators Non-initiators
N %* N %*
Number of people 1,255 11,949
Person years 1,104 11,844
Assessments 1,271 13,531
Assessments with missing data for any variable 304 24 4,176 31
Assessments in 1:5** matched sample 908 71 3,790 28
Person years 780 3,247
Assessments in 1:5** matched sample after multiple imputation 1,201 94 5,047 37
Person years 1,044 4,408
* Percentage of all assessments.
** As the algorithm used to calculate the matched groups allowed initiator to have up-to (not exactly) ﬁve matches within the pre-speciﬁed calliper bounds the ﬁnal ratio
was not 1:5 (actual ratio 1:4.3).
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Table 2
Comparison between initiators and non-initiators on baseline covariates, classiﬁed within 8 groups, prior to and post propensity score matching.
Variable Initiators N = 1271 Non-initiators N = 13,531 Standardised difference (%)
N/mean %/SD N/mean %/SD All Matched
Group 1: demographic variables
Gender
Male 955 75 10,422 77 4.4 2.1
Female 316 25 3109 23
Mean age 31.1 7.0 31.7 7.3 8.1 3.4
Ethnicity
White 1084 85 11,246 83 4.6 0.8
Non-white 106 8 1284 9
Missing 81 6 1001 7
Region
Eastern 87 7 1119 8 5.4 0.0
East Midlands 185 15 1465 11 11.2 3.2
London 85 7 1246 9 9.3 2.8
North East 70 6 677 5 2.3 5.1
North West 264 21 2676 20 2.5 1.9
South East 154 12 1728 13 2.0 1.4
South West 84 7 1031 8 3.9 0.5
West Midlands 166 13 1699 13 1.5 1.0
Yorkshire& Humber 176 14 1890 14 0.3 1.8
Group 2: relating to the assessment
Purpose of assessment
Pre-sentence report 456 36 2695 20 36.2 1.1
Start community sent 366 29 3736 28 2.6 4.8
Sentence review 119 9 2264 17 22.0 0.0
Start licence 135 11 2361 17 19.8 1.5
End sentence 195 15 2475 18 7.9 3.3
Sentence tied to the assessment
Community 596 47 5225 39 15.4 2.0
Custody 89 7 1556 12 17.7 1.3
Suspended 159 13 1448 11 4.7 4.1
Other 198 16 1993 15 1.0 3.0
Community punishment 111 9 1641 12 13.1 6.0
Missing 118 9 1668 12
Mean assessment no. 1.11 0.33 1.13 0.36 5.0 3.9
Assessment ﬁnancial year
2005–2006 355 28 4213 31 7.0 4.3
2006–2007 287 23 3073 23 0.3 0.5
2007–2008 308 24 3065 23 3.7 1.3
2008–2009 321 25 3180 24 4.1 2.5
Group 3: Offending which led to assessment
Offence which resulted in the probation assessment
Violence/sexual 103 8 1273 9 4.7 0.0
Serious acquisitive 210 17 2445 18 4.2 1.5
Non-serious acq. 618 49 5991 44 8.6 1.1
Drugs offences 155 12 1747 13 2.3 1.0
Other 176 14 1945 14 1.6 2.2
Missing 9 1 130 1
Are current offence(s) an escalation in seriousness from previous offending?
Yes 234 18 2823 21 6.5 0.0
No 1007 79 10,342 76
Missing 30 2 366 3
Are current offence(s) an established pattern of similar offending?
Yes 1044 82 10,840 80 4.9 0.9
No 217 17 2560 19
Missing 10 1 131 1
Group 4: Drug use/problems
Was there evidence of motivation due to addictions/perceived needs?
Yes 887 70 9055 67 5.0 4.2
No 363 29 4136 31
Missing 21 2 340 3
Did drugs act as a disinhibitor?
Yes 862 68 8774 65 5.8 6.5
No 395 31 4553 34
Missing 14 1 204 2
Daily use of heroin?
Yes 1009 79 9720 72 17.7 1.9
No 262 21 3811 28
Currently injects heroin
Yes 516 41 4896 36 9.1 5.1
No 755 59 8635 64
Previously (but not currently) injected heroin
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Table 2 (Continued)
Variable Initiators N = 1271 Non-initiators N = 13,531 Standardised difference (%)
N/mean %/SD N/mean %/SD All Matched
Yes 279 22 3076 23 1.9 0.3
No 992 78 10,455 77
Other opiates or (non-prescribed) methadone
Yes 136 11 1543 11 2.2 0.0
No 1135 89 11,988 89
Crack use
No 765 60 7627 56 7.8 7.9
Occasionally 133 10 1286 10 3.2 4.1
Frequently 373 29 4618 34 10.3 5.8
Previously used crack
Yes 350 28 3338 25 6.5 2.0
No 921 72 10,193 75
Cocaine/amphetamine use
Yes 71 6 851 6 3.0 3.4
No 1200 94 12,680 94
Benzodiazepine use
No 1157 91 12,425 92 2.8 1.9
Occasionally 40 3 316 2 5.0 1.3
Frequently 74 6 790 6 0.1 1.3
Other drug used?
Yes 60 5 692 5 1.8 4.3
No 1211 95 12,839 95
A current injector of a drug aside from heroin?
Yes 410 32 4412 33 0.7 3.7
No 861 68 9119 67
Violent behaviour related to drug use?
Yes 263 21 3129 23 6.1 6.3
No 998 79 10,258 76
Missing 10 1 144 1
Motivated to tackle drug misuse?
Yes 368 29 3431 25 8.1 2.7
Somewhat 754 59 7859 58 2.6 1.6
No 145 11 2201 16 14.1 1.3
Missing 4 40
Drug use and obtaining drugs a major activity/occupation?
No 140 11 1721 13 5.3 1.1
Somewhat 470 37 4795 35 3.1 1.8
Signiﬁcantly 659 52 6978 52 0.4 2.4
Missing 2 37
Drug misuse issues linked to risk of serious harm, risks to the individual and other risks?
Yes 814 64 8274 61 6.2 5.1
No 445 35 5144 38
Missing 12 1 113 1
Drug misuse issues linked to offending behaviour?
Yes 1213 95 12,829 95 3.7 4.7
No 49 4 623 5
Missing 9 1 79 1
Group 5: Alcohol
Did alcohol act as a disinhibitor?
Yes 178 14 2337 17 9.8 0.9
No 1046 82 10,530 78
Missing 47 4 664 5
Is current alcohol use a problem?
No 966 76 9687 72 10.1 0.5
Somewhat 166 13 1829 14 1.4 1.6
Signiﬁcantly 128 10 1886 14 12.0 1.1
Missing 11 1 129 1
Binge drinking or excessive use of alcohol in the last 6 months?
Yes 280 22 3415 25 7.7 2.4
No 980 77 9968 74
Missing 11 1 148 1
Frequency and level of alcohol in the past
No problems 897 71 9155 68 6.1 1.5
Some problems 125 10 1536 11 5.0 0.0
Signiﬁcant problems 238 19 2694 20 3.1 1.7
Missing 11 1 146 1
Motivated to tackle alcohol misuse?
No problems 1030 81 10,449 77 9.3 3.2
Some problems 188 15 2260 17 5.4 2.2
Signiﬁcant problems 41 3 669 5 8.8 2.5
Missing 12 1 153 1
Alcohol misuse linked to offending behaviour
Yes 326 26 3884 29 7.3 3.5
No 935 74 9467 70
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Although an extensive set of covariates were available from
probation assessments, in addition to historical offending infor-
mation from police records, bias by unobserved confounding
cannot be ruled out. The probation interview is speciﬁcally
designed to assess future offending likelihood and has previously
shown utility in this regard, (Howard, 2011; Howard & Moore,
2009) however they might be less effective at identifying drug
treatment need. Given that most covariates came from self-report,
disclosure bias may mask true differences between groups. One
study of the inter-rater reliability of probation interviews
concluded that questions relating to drug use and accommodation
had good reliability, whilst those relating to prior alcohol use and
risk of serious harm had poor reliability (Morton, 2009). In England
and Wales, when the cause of death is deemed to be unnatural then
it is subject to a coroner inquest. Coding of the cause of death from
a coroner’s report is subject to error, and there may be some
familial pressure to code the death as something other than drug-
related, resulting in an underreporting of the number of DRPs.
One reason to believe that residual confounding exists is that
there is no compelling theory to support an increase in offending
following treatment contact, albeit the small one observed here.
There is some confounding evident in the analysis: the estimated
increase in offending, associated with being an initiator, changed
from twenty to eight percent after propensity-score matching. The
amount of unobserved confounding would have to be greater than
that observed to change the inference towards a positive effect of
treatment contact and given the number and range of variables
used to calculate propensity scores, this seems unlikely. It should
be noted that a recent UK-based randomised trial (Holland et al.,
2014) found a similarly counter-intuitive result: supervised
Table 2 (Continued)
Variable Initiators N = 1271 Non-initiators N = 13,531 Standardised difference (%)
N/mean %/SD N/mean %/SD All Matched
Missing 10 1 180 1
Group 6: Employment/housing
Unstable accommodation
Yes 755 59 7504 55 7.7 0.9
No 506 40 5882 43
Missing 10 1 145 1
Unemployed
Yes 1166 92 12,287 91 1.6 0.4
No 94 7 1052 8
Missing 11 1 192 1
In receipt of beneﬁts?
Yes 1050 83 10,891 80 4.5 1.2
No 198 16 2320 17
Missing 23 2 320 2
Financial issues linked to offending behaviour
Yes 1018 80 10,594 78 4.2 4.9
No 243 19 2806 21
Missing 10 1 131 1
Group 7: Mental/physical wellbeing
Current psychiatric problems
No problems 1083 85 11,216 83 5.9 2.5
Some problems 124 10 1371 10 1.3 0.4
Signiﬁcant problems 63 5 909 7 7.6 4.5
Missing 1 35
History of psychiatric treatment
Yes 111 9 1375 10 4.9 4.9
No 1160 91 12,156 90
Emotional wellbeing linked to offending behaviour
Yes 503 40 5537 41 2.9 2.9
No 754 59 7823 58
Missing 14 1 171 1
Has physical or mental health conditions which need to be taken into account
Yes 524 41 5777 43 3.2 6.0
No 727 57 7506 55
Missing 20 2 248 2
Group 8: Offending history from PNC records
Mean years since last recorded offence 0.35 0.69 0.45 0.68 15.7 3.3
Mean previous acquisitive crimes
<4 weeks 0.32 0.75 0.21 0.63 17.2 4.5
4wks to 6 months 1.21 1.71 1.06 1.68 8.9 1.4
6 months to 1 year 0.89 1.59 0.90 1.54 0.8 2.1
Over one year 20.7 22.0 21.6 21.2 3.9 7.8
Previous non-acquisitive crimes
<4 weeks 0.14 0.53 0.11 0.49 5.4 4.5
4 weeks to 6 months 0.65 1.24 0.64 1.34 0.8 0.3
6 months to 1 year 0.52 1.09 0.63 1.33 8.8 1.6
Over one year 13.8 14.9 14.7 15.3 6.0 6.8
Breach offences
<4 weeks 0.17 0.49 0.18 0.52 2.1 0.0
> 4weeks 8.60 8.21 8.73 7.59 1.7 1.0
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consumption of methadone over three months, compared to one-
week supervision, resulted in an increase in offending (OR = 3.37,
95% CI: 1.3–8.9). In conjunction with this, our ﬁnding may warrant
fresh investigation into the relationship between treatment and
offending.
Utilising records from probation assessments allows subjects to
be identiﬁed prior to entering treatment and provides an extensive
set of variables to achieve balance. This approach has previously
been used to assess the effect of alcohol treatment referral on
recidivism — a study that found no overall impact of the
intervention (McSweeney, 2014). Alternative observational study
designs compare treated and untreated periods. The DRP-risk
reduction estimated here was consistent with that seen in such
studies (Cornish, Macleod, Strang, Vickerman, & Hickman, 2010;
Pierce, Bird et al., 2016; Sordo et al., 2017). In contrast to the
ﬁndings presented here, studies of this type that investigate
offending outcomes have tended to show lower rates in treatment
than those observed out of treatment (Bukten et al., 2011; Lind,
Chen, Weatherburn, & Mattick, 2005).
One difference between these studies and the current one is the
different measures of treatment effectiveness. The object of the
current analysis is to estimate the effect of initial contact with
treatment, whilst other observational studies tend to estimate the
effect of receiving treatment. The effect of initiating treatment is
also likely to be more conservative because addiction-treatment
tends to be most effective whilst subjects are being treated. To
illustrate, in one Australian study of offending among prison
leavers, comparing those who were on methadone maintenance at
baseline with those who were not resulted in a Hazard ratio of 0.98
(95% CI: 0.88–1.09) and analysing according to being in treatment
resulted in an HR of 0.80 (95% CI: 0.71–0.90) (Larney, Toson, Burns,
& Dolan, 2012). One difﬁculty in measuring the effect of receiving
treatment is that, because treatment exposure changes over
follow-up, time-updated covariates are needed to account for
confounding, but in most cases such variables will not be available.
Even if sufﬁcient data were collected, when treatment affects the
future values of a time-dependent confounder standard estimation
methods will still produce biased estimates (Pierce, Dunn, & Millar,
2016). Regardless, the effect of initial treatment contact is of
greater interest when assessing the effectiveness of current policy,
as is the aim of the present analysis.
Another reason why our study might fail to reveal an effect of
treatment on offending is because the cohort is restricted to those
who were identiﬁed in the criminal justice system, with 63% of
initiators have been referred to treatment from within the criminal
justice system (compared to the national proportion of 26%)
Fig. 2. Distribution of propensity scores, averaged across 10 multiple imputation
datasets, for initiator and non-initiator assessments where height indicates density
of subjects.
Table 3
Results of drug-related poisoning mortality analyses, comparing initiators and non-initiators: unmatched, propensity score matching and propensity score matching
following multiple imputation (Number of assessments = 14,802).
Analysis Group Deaths Person years Rate, per 1000 person year [95% CI] Hazard ratio [95% CI] p-value
Un matched Initiators 3 1104 2.7 [0.9, 8.4] 0.40 [0.13, 1.26] 0.116
Non-initiators 81 11,844 6.8 [5.5, 8.5] Ref
1:5 matched Initiators 2 780 2.6 [0.6, 10.2] 0.30 [0.09, 0.99] 0.048
Non-initiators 25 3251 7.7 [5.2, 11.4] Ref
1:5 matched after MI Initiators 3 1049 2.9 [0.9, 8.9] 0.42 [0.17, 1.04] 0.060
Non-initiators 30 4413 6.8 [4.8, 8.9] Ref
Table 4
Results of acquisitive crime analyses, comparing initiators and non-initiators: unmatched, propensity score matching and propensity score matching following multiple
imputation (No of assessments = 14,802).
Analysis Group Crimes Person years Rate, per person year [95% CI] Hazard ratio [95% CI] p-value
Unmatched Initiator 544 666 0.82 [0.75, 0.89] 1.22 [1.11, 1.33] <0.001
Non-initiators 5261 7965 0.66 [0.64, 0.68] Ref
1:5 matched Initiators 391 464 0.84 [0.76, 0.93] 1.08 [0.99, 1.17] 0.102
Non-initiators 1579 2079 0.76 [0.72, 0.80] Ref
1:5 matched after MI Initiators 513 636 0.81 [0.74, 0.88] 1.10 [1.02, 1.18] 0.015
Non-initiators 2052 2860 0.72 [0.69, 0.75] Ref
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(National Treatment Agency for Substance Misuse, 2011). The lack
of evidence for criminal justice referral as a method of accessing
treatment has been identiﬁed in a recent systematic review
(Hayhurst et al., 2015).
The results presented may be due to poor treatment adherence
amongst those who started treatment and the negative effects of
leaving treatment. It is noted that 6.4% of initiators (81/1271) did
not receive any treatment following their triage appointment and
we cannot expect treatment contact to be effective for these. A
future analysis could use a similar design to investigate the effect of
discontinuing treatment, selecting patients in long-term treat-
ment and comparing those who discontinue treatment with those
who do not. Irrespective of the lack of an effect on crime, it is
striking that a very small proportion of those identiﬁed at a formal
OASys assessment interview as regular heroin users, for whom
treatment would appear to be indicated, subsequently went on to
seek treatment.
The ﬁndings reported here raise questions concerning the
referral of drug using offenders for treatment as a means to reduce
crime, insofar as initiation of contact was not associated with a
lower risk of offending among these CJS-involved participants.
However, if the effect on DRP-deaths was established with further
good-quality evidence, this could provide sufﬁcient justiﬁcation
for continued investment, especially given the record-high number
of DRP-deaths in the most recent statistics published in England
and Wales (Ofﬁce for National Statistics, 2016). It has been
previously noted that the criminal justice system has lagged
behind medical research in adopting RCTs (Bird, Goldacre, & Strang,
2011) and this ought to be addressed if we are to improve
outcomes for offenders.
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